Why is Indrayani Biotec falling/rising?

As of 09-Sep, Indrayani Biotech Ltd's stock price is currently at 12.24, reflecting an increase of 0.24 or 2.0%. Today's price movement indicates a trend reversal as the stock has gained after two consecutive days of decline. While the stock has performed inline with the sector, it remains higher than its 5-day moving averages but lower than its 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has shown a return of +4.97%, although it has significantly underperformed over the longer term, with a -10.33% return over the past month and a staggering -66.36% year-to-date. The company has faced ongoing challenges, including negative results for the last five consecutive quarters, a high Debt to EBITDA ratio, and a weak long-term fundamental strength, which collectively contribute to its classification as a strong sell.
In the broader market context, the stock's recent short-term performance of +4.97% over the past week contrasts with the Sensex's return of +1.18% during the same period, indicating that it has outperformed the benchmark recently. However, the long-term picture remains bleak, with the stock having generated a return of -74.99% over the past year, significantly underperforming the BSE500, which has seen a decline of only -0.56%. The falling participation from institutional investors, who have reduced their stake, further underscores the stock's risky nature and lack of confidence in its recovery potential.